Hims Stock

forhims.comHealthcare / Other HealthcareFounded: 2017Funding to Date: $197MM

Hims and hers is a provider of FDA-approved, medical-grade health and wellness products.

Register To Buy and Sell Shares

For more details on financing and valuation for Hims, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Hims’ valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Hims.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Pat Carroll
Chief Medical Officer
Spencer Lee
Chief Financial Officer
Jack Abraham
Co-Founder & Executive Chairman
Andrew Dudum
Founder & Chief Executive Officer
Joe Spector
Senior Vice President of Partnerships and Operations

Board Members

Thomas Rodgers
Jack Abraham

Frequently Asked Questions About Hims’ Stock

Can you buy Hims’ stock?
Hims is not publicly traded on NYSE or NASDAQ in the U.S. To buy Hims’ stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell Hims’ stock?
Yes, you can sell stock of a private company like Hims. Forge can help you sell your Hims stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is Hims’ stock price?
Hims is a privately held company and therefore does not have a public stock price. However, you may access Hims’ private market stock price with Forge Data.
What is Hims’ stock ticker symbol?
Hims does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

$380 billion juggernaut UnitedHealth is getting into one of the hottest parts of healthcare, and that should be a warning for upstarts like Hims and Ro
UnitedHealth's revamped Optum Store brings new competition to the direct-to-consumer healthcare market.
The CEO of telemedicine Hims is 'optimistic' about Biden's healthcare plan: 'There's a great sense of relief.'
Hims just went public in a $1.6 billion SPAC deal and the CEO tells Insider he's 'optimistic' about Biden's healthcare plan.
Hims CEO took a trip to China before COVID hit and still sees Asia as a 'massive market opportunity.'
As the company goes public in a $1.6 billion SPAC deal, the CEO of Hims reveals how he's looking at the Chinese market.
Updated on: Apr 14, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.